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Background: The distal revascularization and interval ligation (DRIL) procedure has evolved as the optimal treatment for
access-related hand ischemia despite concerns about its durability. This study was designed to review our institutional
experience and objectively define its mid-term outcome.
Methods: A retrospective review of all patients undergoing the DRIL procedure was performed. The diagnosis of severe
hand ischemia was made based primarily upon clinical presentation, but confirmed with noninvasive imaging in select
cases. The DRIL conduit was selected based upon noninvasive imaging (vein conduit criteria: saphenous > arm; diameter
>3 mm) and the proximal anastomosis was positioned >7 cm from the access anastomosis. The DRIL bypasses were
followed in a graft surveillance protocol and remedial procedures performed as dictated by clinical or ultrasound scan
findings.
Results: Sixty-four DRIL procedures were performed in 61 patients (age - 58  13 standard deviation [SD], female – 62%,
diabetic – 72%). The index access procedures included: autogenous brachiocephalic – 46%, autogenous brachiobasilic –
31%, autogenous brachioaxillary translocated femoral vein – 20%, other –3%. The precipitating symptoms were pain
(25%), paresthesia (34%), motor dysfunction (24%), and tissue loss (17%); a pre-emptive DRIL was performed in 5
patients. The timing of the DRIL relative to the index access was dictated by the symptoms: <24 hrs – 19%; 1 day < DRIL
<7 days – 29%; 7 days < DRIL <30 days – 8%; >30 days – 44%. Perioperative mortality rate was 3% and the complication
rate was 22% (wound – 14%). The DRIL procedure relieved the ischemic symptoms in 78% of the cases (residual
symptoms: paresthesia – 13%; pain – 5%; tissue loss – 4%; motor – 2%). The DRIL also resulted in significant (P < .05)
increases in both the wrist/brachial index (WBI) and digital/brachial index (DBI) with the mean increases of 0.34  0.26
and 0.41  0.21, respectively. The primary DRIL patency rates ( standard error of the mean [SEM]) were 77  8%,
74  9%, and 71  9% at 1 year, 3 years, and 5 years, respectively, while the corresponding secondary patency rates were
81  7%, 76  9%, and 76  9%, and the survival rates were 71  6%, 59  7%, and 33  9%. The index access procedure
went on to mature sufficiently for cannulation in 68% of the cases when the DRIL was performed early (ie, <3 months
from index access); all accesses functional at the time of the DRIL were used for dialysis throughout the perioperative
period.
Conclusion: The DRIL procedure safely and effectively relieves the symptoms of severe access-related hand ischemia while
preserving the access. The midterm results suggest that the DRIL bypasses are durable, although long-term graft
surveillance may be justified given the observed failures. ( J Vasc Surg 2008;48:926-33.)Hand ischemia is one of the most worrisome, non-fatal
complications after upper extremity arteriovenous hemodi-
alysis access procedures. The spectrum of ischemic symp-
toms ranges from a cool extremity (grade 1) to severe pain
with tissue loss (grade 3)1 and can lead to a dysfunctional
hand requiring amputation, if untreated. Additionally, even
patients addressed in a timely fashion can develop an isch-
emic neuropathy and persistent pain.2 Unfortunately,
access-related hand ischemia (aka, steal syndrome) is com-
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926mon with the incidence of any type of symptoms (ie, grades
1-3) ranging up to 20% and the more severe grades up to
10%.3-6 A variety of clinical characteristics (eg, age, gender,
diabetes, peripheral arterial occlusive disease)4,6-9 and non-
invasive laboratory criteria (eg, digital brachial index)9 have
been identified to help predict which patients are at risk.
However, these preoperative predictors are collectively in-
adequate to determine when hand ischemia is inevitable.
The treatment options for patients with severe access-
related hand ischemia include simple ligation or remedial
procedures to improve blood flow to the hand while main-
taining the access. Although it effectively reverses the isch-
emic symptoms, ligation sacrifices the access, and thereby
limits a patient’s longer-term access options. The various
remedial procedures designed to salvage the access include
limiting the flow through the access itself (ie, banding,
lengthening, and anastomotic narrowing) or directly revas-
cularizing the hand (ie, correction of inflow stenoses, distal
revascularization, and distal revascularization with interval
ligation (DRIL)). The DRIL procedure has evolved as the
optimal remedial treatment and has been reported to effec-
tively reverse the hand ischemia and preserve the ac-
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this procedure is limited and concerns have been raised
about the complexity of the procedure, the necessity of
ligating the brachial artery, and the long-term patency rates
of the bypass. This study was designed to review our
institutional experience with the DRIL procedure and ob-
jectively define its midterm outcome.
METHODS
Experimental design. All patients undergoing any
permanent hemodialysis access procedure at the University
of Florida College of Medicine between Feb 1998 and Dec
2007 were identified by review of a prospectively main-
tained procedural database. The patients requiring defini-
tive treatment (ie, ligation or DRIL) for severe (grades 2 or
3) access-related hand ischemia were then identified within
the larger subset of access procedures. The complete hos-
pital and outpatient medical records of those patients re-
quiring a DRIL were then retrospectively reviewed and the
perioperative and midterm outcomes determined. The
study was approved by the Institutional Review Board
(approval # 646-2007).
Clinical practice. Patients were evaluated and treated
by a group of 8 board-certified or board-eligible vascular
surgeons at a tertiary-care university medical center. All
patients presenting for their initial permanent hemodialysis
access procedure were evaluated using our prospectively
validated algorithm designed to optimize the use of autog-
enous accesses.15 Briefly, patients underwent both arterial
and venous upper extremity imaging in the noninvasive
vascular laboratory. A tentative operative plan was gener-
ated based upon the results of the noninvasive testing.
Invasive imaging with arteriography and/or venography
was used to confirm the initial plan in select patients with
presumed significant occlusive disease. Criteria for a suit-
able outflow vein included a diameter 3 mm, a length
spanning the forearm/arm and no ipsilateral central vein
stenoses/occlusions. Criteria for a suitable inflow artery
included no hemodynamically significant proximal stenoses
and adequate diameter (ie, brachial 3 mm, radial 2
mm). The hierarchy of access procedures included autoge-
nous radiocephalic  autogenous radiobasilic  autoge-
nous brachiocephalic  autogenous brachiobasilic  pros-
thetic forearm/arm  translocated femoral/popliteal
vein.8
The diagnosis of access-related hand ischemia was
based primarily upon the clinical presentation and physical
examination. Noninvasive imaging including upper ex-
tremity (ie, brachial/radial/ulnar/digit) pressures and the
corresponding velocity waveforms were obtained in equiv-
ocal cases to confirm the diagnosis. Mild ischemia (grade 1)
was treated expectantly with definitive treatment reserved
for selected patients with moderate ischemia (grade 2) and
all of those with severe ischemia (grade 3). Upper extremity
arteriography with evaluation of the complete arterial tree
from the aortic arch to the digits was used selectively to
identify and correct any inflow lesions. Definitive treatment
of persistent hand ischemia included access ligation orDRIL with the choice contingent upon patient comorbidi-
ties, type of access (autogenous vs prosthetic), onset of
ischemia (early vs late), likelihood of autogenous access
maturing sufficient for cannulation, and future access op-
tions.
The DRIL procedure was performed as previously de-
scribed.16 Briefly, the proximal anastomosis of the brachio-
brachial artery bypass was placed 7 cm from the access
anastomosis. The distal bypass anastomosis was placed im-
mediately distal to that for the access and was configured
end-side or end-end with ligation or transaction/oversew-
ing of the brachial artery immediately proximal to the distal
bypass anastomosis. The choice (ie, end-side or end-end)
was dictated by which configuration looked the best and
was easiest to perform although end-side anastomosis was a
functional end-end one given the proximal ligation. Poten-
tial upper and lower extremity venous conduits for the
DRIL were identified using ultrasound scan. Greater sa-
phenous vein (3 mm) was used preferentially with the
alternative choices dictated by availability or surgeon pref-
erence (arm vein  femoral vein  cadaveric vein  pros-
thetic). Every attempt was made to preserve any available
suitable arm vein for future autogenous accesses. The ve-
nous conduits were used both in the reversed and non-
reversed fashion with the choice dictated by the size match
between the artery/vein when relevant (ie, larger vein end
with larger artery).
Postoperative surveillance of the DRIL bypass included
upper extremity arterial pressures/waveforms and duplex
ultrasound scanning of the DRIL bypass as previously
described for our lower extremity bypasses.17 Surveillance
was performed at 1 month, 3 months, 6 months, 9 months,
12 months, and then every 6 months thereafter. Additional
imaging and/or treatment was performed for recurrent
hand symptoms, significant decreases in the arterial pres-
sures (ie, 15 mm Hg decrease in wrist pressure), and/or
abnormal graft scans (ie, mean graft velocity 50 cm/s,
maximum velocity ratio 3.5).18
Data analysis. Patient comorbidities were defined as
any prior history of hypertension (any antihypertensive),
coronary artery disease (angina, coronary artery bypass,
percutaneous coronary angioplasty), peripheral vascular oc-
clusive disease (claudication, ankle-brachial index 0.9,
prior lower extremity revascularization), chronic obstruc-
tive pulmonary disease (smoking history 20 packs/year,
abnormal pulmonary function tests, medication), diabetes
mellitus (oral hypoglycemics, insulin), congestive heart fail-
ure (New York Heart Association Class II or greater), and
cerebrovascular occlusive disease (transient ischemic attack,
stroke, carotid endarterectomy/angioplasty), graft patency
was objectively determined by ultrasound scan or arteriog-
raphy scan. DRIL patency (primary, primary assisted, sec-
ondary) and patient survival were determined using the
Kaplan-Meier method. Survival was confirmed by interro-
gating the National Death Index. The pre-operative and
postoperative wrist/brachial indices (WBIs) and digital/
brachial indices (DBIs) were compared with a paired t test
and a P value  .05 was accepted as significant. All values,
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RESULTS
A total of 77 patients with severe access-related hand
ischemia were treated with a DRIL procedure (61 patients)
or access ligation (16 patients) during the time course of
the study. During this interval, 1519 access-related surgical
procedures (exclusive of dialysis catheters) were performed
including both new constructions and revisions. The inci-
dence of severe access-related hand ischemia requiring liga-
tion or DRIL was 6% among the new access procedures. A
total of 64 DRIL procedures were performed in the 61
patients. The mean patient age was 59  13 years and the
majority was female, hypertensive, diabetic, and on hemo-
dialysis (Table I). Notably, 10% had a prior episode of
access-related hand ischemia. The brachial artery was the
inflow source for all of the index access procedures with
the brachiocephalic autogenous access configuration being
themost common (Table I). A significant proportion of the
patients had an autogenous brachioaxillary access using the
translocated femoral/popliteal vein while only 2 patients
had a prosthetic access. The primary ischemic symptoms
that precipitated the DRIL procedures were pain (25%),
paresthesia (34%), motor dysfunction (24%), and tissue loss
(17%). A planned, pre-emptive DRIL (ie, simultaneous
with the index access procedure) was performed in 5 pa-
tients because of a prior history of access-related hand
ischemia (n  3) and/or severe forearm arterial occlusive
disease in conjunction with digital gangrene (n  2).
Noninvasive vascular laboratory studies were obtained to
confirm the clinical diagnosis in approximately half of the
patients (n  33). The mean preoperative (ie, pre DRIL)
WBI was 0.46  0.19 and the mean DBI was 0.25  0.23
with the latter used primarily for patients with non-
compressible arteries at the wrist (Fig 1). The majority (83%)
of the patients had an upper extremity arteriogram prior to
their index access procedure or immediately prior to the
Table I. Demographics, comorbidities, and access
configuration
Demographics
Age 59  13
Gender (% male) 38%
Comorbidities
End-stage renal disease 92%
Hypertension 74%
Diabetes mellitus 72%
Coronary artery disease 36%
Cerebrovascular occlusive disease 23%
Congestive heart failure 20%
Peripheral vascular occlusive disease 13%
Prior access-related hand ischemia 10%
Access configuration
Brachiocephalic autogenous 46%
Brachiobasilic autogenous 31%
Brachioaxillary translocated femoral vein 20%
Brachioaxillary prosthetic 3%DRIL. A significant arterial lesion was found on the arte-riogram proximal to the brachial artery in 3 patients (sub-
clavian stenosis – 2, brachial artery stenosis – 1) prior to the
index access procedure and these were corrected to facili-
tate the procedure itself (ie, the index access). An additional
3 patients were found to have significant inflow lesions
(subclavian stenosis – 2, brachial artery occlusion) during
evaluation of their hand ischemia (ie, postoperative index
access procedure); these were corrected at the time of the
DRIL procedure.
The DRIL procedure was performed within 7 days of
the index access procedure in almost half of the cases as
dictated by the acuity/severity of the symptoms: 24
hours – 19%; 1 dayDRIL7 days – 29%; 7 daysDRIL
30 days – 8%; 30 days – 44%. The greater saphenous
vein was used as the conduit in themajority of cases (greater
saphenous vein – 75%, basilic/cephalic vein – 19%, cadav-
eric vein – 5%, femoral vein – 2%, lesser saphenous vein –
2%). The in-hospital mortality rate after the DRIL was 3%
with a single death resulting from withdrawal of hemo-
dialysis and a second from a presumed arrhythmia. The
non-fatal complication rate was 22% with the itemized
breakdown including wound (14%), respiratory (3% -
pneumonia, re-intubation), vascular (3% - lower extremity
ischemia requiring amputation from femoral/saphenous
vein harvest wounds; compartment syndrome), and cardiac
(2% - arrhythmia) causes. The majority of the wound
complications were mild although 2 patients required pro-
longed hospitalizations. The DRIL procedure relieved the
precipitating ischemic symptoms in 78% of the cases (resid-
ual symptoms: paresthesia – 13%; pain – 5%; tissue loss – 4%;
motor – 2%). Notably, the residual paresthesia and motor
compromises were relatively minor with the latter associ-
ated only with very fine movements. Access ligation was
required in a single patient with ongoing, severe pain
despite a patent DRIL bypass and no identifiable, hemody-
namically significant inflow lesion. All but 2 of the patients
that presented with tissue loss were able to heal their
wounds; the exceptions had severe forearm arterial occlu-
sive disease as documented by arteriography. Both the
Fig 1. The mean preoperative (pre) and postoperative (post)
wrist/brachial (WBI) and digital/brachial (DBI) indices are
shown. Significant increases (P .05) were noted for both indices
after the DRIL procedure*.WBIs and DBIs increased significantly (P  .05) with
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respectively (Fig 1). This corresponded to a mean increase
(preoperative vs postoperative) of 0.34  0.26 for the
WBIs and 0.41 0.21 for the DBIs. The access maturation
rate was 68% for the patients in which the DRIL procedure
was performed early after the index access procedure (ie,
prior to the index access every being cannulated for dialy-
sis). All of the accesses in use at the time of the DRIL
procedure were used throughout the peri-operative period
without interruption.
The mean follow-up after the DRIL procedure was
12  16 months (range, 0–66). The primary DRIL pa-
tency rates ( SEM) were 77 8%, 74 9%, and 71 9%
at 1 year, 3 years, and 5 years (Fig 2, Appendix I, online
only), respectively, while the corresponding secondary pa-
tency rates were 81  7%, 76  9%, and 76  9% (Fig 3,
Appendix II, online only). The primary assisted and sec-
ondary patency rates were identical since all DRIL bypasses
that thrombosed were abandoned. A total of 7 DRIL
bypasses failed during follow-up. Three of the patients
presented with recurrent symptoms (pain – 2, tissue loss)
and underwent a redo DRIL bypass; one of which failed a
second time requiring access ligation. Three other patients
were asymptomatic after their DRIL bypass failed and did
not required additional treatment. Notably, all 3 of the
DRIL procedures performed with cadaveric vein throm-
bosed during follow-up. The patient survival after the
DRIL procedure was 71 6%, 59 7%, and 33 9% at 1
year, 3 years, and 5 years, respectively, with a median
survival of 43 months (Fig 4, Appendix III, online only).
DISCUSSION
The results of our study further establish the benefits of
the DRIL procedure as a safe, definitive treatment for
access-related hand ischemia. Notably, it relieved the pre-
cipitating symptoms in the majority of patients with a
success rate approaching 90% if the patients with residual
Fig 2. The Kaplan-Meier curve for the primary patency of the
DRIL bypass is shown with the standard error bars. The standard
errors were 10% throughout the time interval analyzed. The
number of patients at risk are shown above the curve. The com-
plete data can be found in Appendix I, online only.paresthesia, presumably resulting from the initial ischemicinjury to the nerve, were excluded. The clinical improve-
ment was supported by the hemodynamic changes as mea-
sured by the WBIs and DBIs. Furthermore, the objectively
documented, mid-term patency rates for the DRIL bypass
were good and neither the patients’ hands nor accesses
appeared to be adversely affected. Perhaps not surprising,
the overall survival for patients requiring a DRIL was poor,
thereby suggesting that the long-term durability of the
DRIL may be a secondary concern. The significance of
these findings is further underscored by the fact that our
study represents the largest published experience.
The results of our study are consistent with the other
similar reports in the literature as summarized in Table II.
Although the objectively documented follow-up is some-
what limited, DRIL patency, symptomatic relief, and access
preservation all appear to be quite good, and, thereby,
negate any reservations about the procedure (ie, concerns
about graft patency, the viability of the hand, requisite need
Fig 3. The Kaplan-Meier curve for the secondary patency of the
DRIL bypass is shown with the standard error bars. The standard
errors were 10% throughout the time interval analyzed. The
number of patients at risk are shown above the curve. The com-
plete data can be found in Appendix II, online only.
Fig 4. The Kaplan-Meier curve for the patient survival is shown
with the standard error bars. The standard errors were 10%
throughout the time interval analyzed. The number of patients at
risk are shown above the curve. The complete data can be found in
Appendix III, online only.to ligate the brachial artery). The graft patency rates are not
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the requirement for adequate inflow. Admittedly, the collec-
tiveDRIL experience is quite small given the 400,000patients
in the United States with end-stage renal disease19,20 and an
estimated 5% incidence of severe hand ischemia necessitat-
ing definitive treatment.3-6
The effectiveness of the DRIL procedure is predicated
upon its ability to reverse the hemodynamic changes asso-
ciated with the creation of an arteriovenous hemodialysis
access. The construction of an access can cause a decrease in
the arterial pressure and blood flow distal to the access
anastomosis. The normal compensatory responses include
an increase in the cardiac output and arterial vasodilation.
When these compensatory mechanisms are inadequate, the
hand may become ischemic. Predictably, a hemodynami-
cally significant inflow (eg, subclavian artery) or outflow
(eg, forearm radial/ulnar) lesion can exacerbate the initial
hemodynamic changes and further inhibit the compensa-
tory responses. Illig et al21 measured the mean pressures
over the course of the brachial artery after a series of access
procedures based on the distal brachial artery (ie, near the
antecubital fossa). They reported that the mean pressure
decreased from 102 mm Hg proximally to 47 mm Hg at
the anastomosis. This gradient did not change after con-
struction of the DRIL, however, the forearm perfusion
pressure (ie, the pressure within the DRIL bypass) was
found to be identical to the proximal brachial artery. Fur-
thermore, compression of the access did not change the
distal perfusion pressures after the DRIL. These hemody-
namic changes support the clinical observation that the
proximal DRIL anastomosis should be sited 7 cm from
the access anastomosis (ie, prior to the brachial artery
pressure gradient). Interestingly, Gradman and Pozriki-
dis22 developed a model to analyze the hemodynamic
changes associated with the various treatments for access-
related hand ischemia and concluded that the DRIL was
the most effective.
A variety of remedial treatments have been described
Table II. Published DRIL series
Study Sample DRIL patency Sym
Haimov10 23 96% @ 2 yrs 100% - im
83% - reso
Katz36 5 100% (mean 7 mos) 83% - imp
Stierli37 6 100% (6-24 mos) 100% - im
Knox11 55 1° - 80% @ 4 yrs (life table) 90% - imp
Lazarides12 23 69% @ 1 yr 100% - res
Diehl38 13 83% @ 2 yrs 100% - im
57% - reso
Korzets39 9 100% (mean 12 mos) 100% -res
Sessa13 18 94% (mean 16 mos) 100% - im
73% - reso
Mwipatayi40 12 100% (median 4 mos) 83% -impr
Walz14 38 NA 67%
Current Study
2008.
64 1° - 71  9 @ 5 yrs
2° - 76  9 @ 5 yrs
(Kaplan-Meier)
78% - resofor access-related hand ischemia.23-25 Clearly, the ultimateobjectives are to salvage hand function and preserve the
access (if at all possible). It is our impression that the DRIL
procedure achieves these objectives most effectively and it is
relatively simple to perform. However, there are specific
scenarios where the other approaches may be useful. Access
ligation is effective, and, theoretically, restores the hand
perfusion to the pre-access state at the expense of the
access. For all practical purposes, it is our second choice for
patients that are not DRIL candidates. Interestingly, the
patient survival in the subset of our patients who underwent
ligation was very poor (median survival 16 months – data
not shown). Despite a recent resurgence,26,27 the strategies
to limit the flow through the access using some form of
“banding” procedure (ie, lengthening the access, narrow-
ing the access, narrowing the anastomosis) have been rela-
tively unsuccessful. The fundamental problem is the inabil-
ity to regulate the access flow to a level that improves the
perfusion of the hand while sustaining dialysis and a patent
access. Both the distal revascularization without ligation28
and the proximalization of the arterial inflow25 (eg, re-
siting the brachial access anastomosis onto the axillary
artery) may restore adequate hand perfusion, but they may
not be as effective as the DRIL procedure from a hemody-
namic standpoint.22 Minion et al24 have described convert-
ing a brachial artery-based autogenous access to a radial
artery based one using an interposition saphenous vein
(RUDI – revision using distal inflow). However, the overall
success rate for radial artery based access procedures in
women, the elderly, and diabetics is fairly poor.29 Finally,
the identification and correction of arterial inflow lesions
has been reported to be effective.30,31 However, our expe-
rience would suggest that the incidence of inflow lesions
may not be as high as suggested by the literature and that
treating the inflow lesion alone may not be sufficient.
The DRIL procedure represents only one component
of a broader strategy to reduce the incidence of hand
ischemia and avoid its long-term sequelae. Contrary to
some reports,32 it is a common problem and should be
relief Access preservation Patient survival
d 46% @ 2 yrs NA
/resolved 100% (mean 7 mos) NA
d/resolved 100% (6-24 mos) NA
/resolved 71% @ 3 yrs (life table) 56% @ 4 yrs (life table)
NA NA
d 71% @ 2 yrs NA
78% (mean 12 mos) NA
d 94% (mean 16 mos) mos) 61% (mean 16 mos)
/resolved NA NA
NA NA
New - 68% maturation
Functional – 100%
continued
33  9 @ 5 yrs
(Kaplan-Meier)ptom
prove
lved
roved
prove
roved
olved
prove
lved
olved
prove
lved
oved
lvedconsidered/anticipated pre-operatively in certain subsets of
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advanced age, female gender, diabetes, peripheral arterial
occlusive disease, large conduits (ie, femoral/popliteal
vein), and multiple prior procedures.4,6-9 Additionally, it
has been our anecdotal impression that a history of access-
related hand ischemia is the strongest predictor of future
events. Noninvasive imaging has proven invaluable to help
select the most appropriate arterial inflow site and help
identify any significant proximal lesions. We have adopted a
selective approach to preoperative invasive imaging and feel
that it is worthwhile given the fact that 40% of the patients
had some type of abnormality on arteriography or venog-
raphy during the prospective validation of our algorithm.15
The operative procedure itself can also be modified in
patients at risk for ischemia. Specifically, the translocated
femoral/popliteal vein access should likely be avoided in
patients at risk for hand ischemia. All arterial inflow lesions
can be corrected simultaneously and a variety of less com-
mon and/or exotic access configurations have been de-
scribed to reduce the incidence of ischemia including siting
the anastomosis on the axillary artery,25 a branch of the
axillary artery33 or the proximal radial artery.34 Indeed, the
preemptive DRIL represents the most aggressive/invasive
approach to reduce the incidence of hand ischemia.35 A
plan should be generated at the time of index access proce-
dure to address the hand ischemia when/if it becomes
problematic and we frequently survey the upper and lower
extremity veins during the pre-operative evaluation to iden-
tify a potential DRIL conduit. Notably, all three of the
DRIL procedures performed with cadaveric conduits
failed, thereby, suggesting that they are a poor alternative
to autogenous vein. Patients should be educated about the
symptoms associated with hand ischemia and engaged in
their own health care given the fact that only half of the
ischemic events necessitating DRIL occurred during the
first month after the index procedure. Lastly, all hand
complaints after an access procedure should be assumed to
be secondary to ischemia despite equivocal findings on
physical examination and/or noninvasive testing.
The current study has several limitations inherent to its
retrospective design. The patients were fairly highly se-
lected. Specifically, the index access configuration was se-
lected based upon the results of the noninvasive/invasive
imaging using defined criteria to identify the best artery/
vein combination for a successful access. Theoretically, this
precluded siting the anastomosis distal to a hemodynami-
cally significant lesion and reduced the overall incidence of
hand ischemia. Although we would contend that this is
optimal, our reported incidence of hand ischemia and the
relevance of arterial inflow lesions may be lower than other
centers. Our follow-up was only fair despite the standard
errors (10%) reported in the patency/survival curves and
it is likely that the actual values may not be as good as the
estimated values. We have adopted an aggressive surveil-
lance protocol for the DRIL patients, but it is often difficult
to convince the patients to comply with the follow-up
regimen. Lastly, the long-term patency rates for the ac-
cesses themselves are not well documented since we gener-ally defer their overall management and surveillance to the
responsible nephrologists after they are suitable for cannu-
lation.
In conclusion, the DRIL procedure safely and effec-
tively relieves the symptoms of severe access-related hand
ischemia while preserving the access. The mid-term results
suggest that the DRIL bypasses are durable although long-
term graft surveillance may be justified given the observed
graft failures.
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Dr. David L. Cull. I would like to congratulate the authors
on this timely study and their well written manuscript. The Uni-
versity of Florida group has a legacy of making significant contri-
butions to the vascular access literature and this paper continues
that legacy.
Dr. Huber and colleagues have presented the largest series of
DRIL procedures reported to date in the literature. At the Univer-
sity of Florida, 6% of new AV access procedures performed during
the period of this study had a DRIL procedure for access-related
steal. In Greenville, we too have a very busy vascular access prac-
tice, and I have no doubt that the incidence of steal in our practice
parallels that of Dr. Huber’s. However, their experience with the
DRIL procedure for the treatment of steal far eclipses our experi-
ence. As I read their manuscript, the differences between our
approaches to access-related steal becomes apparent. Dr. Huber’s
group treats access-related steal early and aggressively with a DRIL
procedure. In his series, nearly 50% of the DRIL procedures wereThirty-four percent of patients underwent a DRIL for the symp-
tom of paresthesia alone. Five patients in this series had a preemp-
tive DRIL procedure prior to fistula creation.
I have considered the DRIL procedure to be an effective opera-
tion for the treatment of steal but an operation that can be quite
challenging particularly in obese patients and in cases where the AV
fistula anastomosis is located close to the terminus of the brachial
artery. Furthermore, I have been concerned about the long-term
patency of the brachial artery bypass and by the fact that symptom
relief is not assured after the procedure. Finally, as noted in Dr.
Huber’s study, many of these patients have a limited life expect-
ancy. Particularly for those patients who have severe distal arterial
occlusive disease who are at the highest risk for steal. Given these
concerns, I have approached patients with access-related steal more
cautiously and have reserved the DRIL procedure for patients who
have functioning fistulas who present with digital gangrene, motor
dysfunction, or significant pain. For patients who present with
paresthesia soon after fistula creation, I have found that for many
JOURNAL OF VASCULAR SURGERY
Volume 48, Number 4 Huber et al 933the symptoms will improve with time. In patients who have severe
steal immediately after AV access creation, I try to determine if
the fistula is likely to mature and if salvage of the fistula is worth
the effort. If maturation of the fistula is in doubt, I generally
ligate the fistula and move to another site. In the current series, for
those patients who had an early DRIL procedure, 32% of the
fistulae never matured.
Now that you have provided us that mid-term outcome for the
DRIL procedure, I would like you to help me put these results into
perspective and provide me with guidance as to when I should
perform aDRIL procedure in my patients with access-related steal?
In other words, should I expand my current approach to access-
related steal? I appreciate the opportunity to discuss this paper.
Dr Huber. Despite your impressions, I would contend that
our practices are almost identical. Although a third of the proce-
dures were performed for paresthesia, I would say that these
episodes of paresthesia were significant in the sense of acute
extremity ischemia. It is not paresthesia in the sense that my hand
bothers me a little bit, but rather truly limb-threatening ischemia in
which we are forced to do something.Many of the patients develop
hand ischemia on the evening of the procedure and I can tell you
that my partners and I wouldn’t be driving back to the hospital in
the middle of the night to do the DRIL procedure unless it was
absolutely necessary. Our incidence of severe hand ischemia isessentially the same as everyone else’s in the literature with a
realistic number being between 5 – 10% for brachial artery based
procedures. Concurrent with these 64 DRIL procedures, we did
17 access ligations for this same problem. We have taken a fairly
aggressive approach to revascularization and I would say that it is
probably justified. There is a subset of patients that have preemp-
tive DRILs, and perhaps we are a couple of standard deviations
from the norm in these instances, but those were people that truly
have terminal access problems and had no other access choice other
than a catheter. I think we all feel the pressures about committing
patients to long-term catheters and the concept that we will just
ligate the access and move on hasn’t worked in our practice. I
would say, albeit somewhat anecdotal, that the incidence of hand
ischemia during subsequent access procedures in someone who has
an episode of hand ischemia is 100%. Accordingly, I would con-
tend you have to have a plan, perhaps even a preemptive plan,
about how you are going to address the inevitable hand ischemia
on the contralateral extremity in this subset of patients. We believe
that the DRIL procedure is very effective. The morbidity and
mortality are generally acceptable, the long-term patency rate is
great and it effectively preserves the access and reverses the isch-
emia. Unfortunately, patient survival is poor, thereby suggesting
that access-related hand ischemia is a marker for a particularly bad
patient outcome.
66 1 71 9
66 1 76 9
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October 2008933.e1 Huber et alAppendix III (online only). Patient survival Kaplan
Meier
Time (mos) Subjects at risk Secondary patency (%) SE
0 59 100 0
1 59 95 3
2 56 92 4
3 52 92 4
4 51 90 4
5 49 88 4
6 48 84 5
7 46 82 5
8 43 79 6
9 41 75 6
10 39 75 6
11 38 71 6
13 35 71 6
14 34 69 6
15 31 67 7
17 30 65 7
18 27 64 7
19 26 64 7
20 25 64 7
22 24 62 7
24 23 62 7
26 22 62 7
30 21 59 7
31 19 59 7
37 18 55 7
41 17 52 8
43 16 49 8
46 14 42 8
48 12 42 8
51 11 42 8
53 10 42 8
57 9 37 8
59 8 33 9
61 7 33 9
66 6 27 9
68 5 27 9
73 4 27 9
74 3 18 9
78 2 18 9
79 1 18 9Appendix I (online only). DRIL primary patency rates
Kaplan Meier
Time (mos) Subjects at risk Secondary patency (%) SE
0 45 100 0
1 45 100 0
2 44 98 1
3 42 95 3
4 40 93 4
5 35 88 5
6 31 85 6
7 27 85 6
8 26 85 6
9 24 85 6
11 21 81 7
12 20 77 8
13 18 77 8
14 17 77 8
15 15 77 8
17 14 77 8
18 13 71 9
22 11 71 9
27 10 71 9
39 9 71 9
42 6 71 9
48 4 71 9
51 3 71 9Appendix II (online only). DRIL secondary primary
patency rates Kaplan Meier
Time (mos) Subjects at risk Secondary patency (%) SE
0 45 100 0
1 45 100 0
2 44 98 2
3 42 95 3
4 40 95 3
5 36 93 4
6 32 93 4
7 29 90 5
8 27 90 5
9 25 90 5
10 22 85 6
11 21 81 7
12 20 81 7
13 19 81 7
14 18 81 7
15 16 81 7
17 15 81 7
18 14 76 9
22 12 76 9
27 11 76 9
39 10 76 9
42 7 76 9
47 5 76 9
48 4 76 9
51 3 76 9
